A Study of GSK1325760A in Healthy Japanese Subjects
NCT00424034 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 32
Last updated 2017-01-19
Summary
To investigate the safety, tolerability, pharmacokinetics and the effect of food on pharmacokinetics after single oral administrations of GSK1325760A
Conditions
- Healthy Subjects
Interventions
- DRUG
-
GSK1325760A
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
GSK Clinical Trials, MD · GlaxoSmithKline
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 20 Years
- Max Age
- 64 Years
- Sex
- MALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2007-01-31
- Primary Completion
- 2007-02-28
- Completion
- 2007-02-28
More Related Trials
-
A Study of JNJ-63733657 in Healthy Japanese Participants
NCT03689153 ·Status: COMPLETED ·Phase: PHASE1
-
A Single and Multiple Dose Study to Investigate Safety, Tolerability and Pharmacokinetics of JNJ-42165279 in Healthy Japanese Male Participants
NCT03564379 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Following Subcutaneous Injection of JNJ-64304500 in Healthy Japanese and Caucasian Male Participants
NCT03002025 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Japanese Men to Test How Well Different Doses of BI 1291583 Are Tolerated
NCT05183347 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Japanese Men to Test How Well Different Doses of BI 764198 Are Tolerated
NCT04665700 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Japanese Men to Test How Different Doses of BI 690517 Are Taken Up in the Body and How Well They Are Tolerated
NCT03608072 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate Safety, Tolerability, and Pharmacokinetics of JNJ-56136379 in Healthy Japanese Adult Participants
NCT02933580 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of AZD5718 After Single and Multiple Ascending Dose Administration to Healthy Japanese Men
NCT03400488 ·Status: COMPLETED ·Phase: PHASE1
-
A Study in Healthy Japanese Men to Test How Well Different Doses of BI 765845 Are Tolerated
NCT06139341 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Single Ascending Dose and Multiple Doses With Titration of TAK-935 in Healthy Japanese Participants
NCT04461483 ·Status: COMPLETED ·Phase: PHASE1
-
Single and Multiple Ascending Dose Study for NKTR-118 and Cross-over Study to Investigate the Effect of Food for NKTR-118 in Japanese Healthy Subjects
NCT01318655 ·Status: COMPLETED ·Phase: PHASE1
-
A Safety, Tolerability and Pharmacokinetics Study of JNJ-54861911 in Healthy Japanese Male Participants
NCT02180269 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Assess the Safety, Tolerability, Pharmacokinetics, Immunogenicity, and Pharmacodynamics of JNJ-64179375 in Healthy Japanese Participants
NCT03080987 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ABSK061 Mini-tablets in Healthy Adult Participants
NCT07007546 ·Status: RECRUITING ·Phase: PHASE1
-
A Study to Investigate Safety, Tolerability, and Pharmacokinetics of DSTA4637S in Healthy Volunteers
NCT02596399 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of LY110140 in Healthy Japanese Male Participants
NCT01569126 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of JNJ-42847922 in Healthy Japanese Male Participants
NCT02555124 ·Status: COMPLETED ·Phase: PHASE1
-
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Japanese and Non-Japanese Participants
NCT02209506 ·Status: TERMINATED ·Phase: PHASE1
-
Study Evaluating the Safety, Tolerability and Pharmacokinetics of NSA-789 in Healthy Japanese Male Subjects
NCT00619736 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics in Healthy Adult Male Participants
NCT03390647 ·Status: WITHDRAWN ·Phase: PHASE1
-
A Study of JNJ-77242113 Following Oral Administration in Healthy Chinese Adult Participants
NCT05703841 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Safety, Tolerability, and Pharmacokinetics of E2082 in Healthy Male Subjects
NCT03402178 ·Status: TERMINATED ·Phase: PHASE1
-
A Study to Investigate the Safety, Tolerability and Pharmacokinetics of MT-6345 in Healthy Subjects
NCT03809039 ·Status: TERMINATED ·Phase: PHASE1
-
This Study is Done in Healthy Japanese Volunteers. It Looks at How Different Doses of BI 705564 Are Taken up in the Body and How Well They Are Tolerated
NCT03747926 ·Status: WITHDRAWN ·Phase: PHASE1
-
Safety, Tolerability and Pharmacokinetics of Single Doses of TS-134 in Healthy Volunteers
NCT03746067 ·Status: COMPLETED ·Phase: PHASE1